Kappac Pharma informs about outcome of board meeting

02 Feb 2019 Evaluate

In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), Kappac Pharma has informed that the Unaudited Financial Results (Standalone) of the Company for the quarter ended 31st December, 2018 were approved by the Board of Directors of the Company at its meeting held on February 01, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×